MARGARET KAYE RALSTON: Open Payments
NPI 1033822770 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 24 payments from 16 companies in 2025. Trend: 2023 $379 · 2024 $662 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Novo Nordisk Inc | 2 | $41 |
| Exact Sciences Corporation | 2 | $38 |
| Amgen Inc. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: TRELEGY ELLIPTA, ELIQUIS, Rybelsus, Cologuard Collection Kit, Kerendia, CAPLYTA, XIFAXAN, FANAPT.
Industry payments across GA — which companies pay providers there.
